KORU Medical Systems, Inc. financial data

Symbol
KRMD on Nasdaq
Location
100 Corporate Drive, Mahwah, NJ
State of incorporation
NY
Fiscal year end
December 31
Former names
REPRO MED SYSTEMS INC (to 6/3/2022)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 376 % -25.1%
Quick Ratio 63.3 % -45.6%
Debt-to-equity 45.8 % +51.3%
Return On Equity -63.1 % -123%
Return On Assets -43.3 % -99.2%
Operating Margin -22.1 % +40.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.8M shares +0.37%
Common Stock, Shares, Outstanding 45.8M shares +0.43%
Entity Public Float 111M USD +54.7%
Common Stock, Value, Issued 493K USD +0.44%
Weighted Average Number of Shares Outstanding, Basic 45.9M shares +0.46%
Weighted Average Number of Shares Outstanding, Diluted 45.9M shares +0.46%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 32M USD +11.6%
Research and Development Expense 5.43M USD -10.9%
Operating Income (Loss) -7.05M USD +33.3%
Nonoperating Income (Expense) 528K USD +25.7%
Income Tax Expense (Benefit) 3.97M USD
Net Income (Loss) Attributable to Parent -12M USD -45.1%
Earnings Per Share, Basic -0.26 USD/shares -62.5%
Earnings Per Share, Diluted -0.26 USD/shares -62.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.81M USD -18.2%
Accounts Receivable, after Allowance for Credit Loss, Current 5.16M USD +27.5%
Inventory, Net 3.93M USD -16%
Assets, Current 18.9M USD -12.7%
Deferred Income Tax Assets, Net 5.45M USD +54.7%
Property, Plant and Equipment, Net 4.55M USD +19.2%
Operating Lease, Right-of-Use Asset 3.06M USD -13.6%
Other Assets, Noncurrent 99K USD +0%
Assets 27.4M USD -22.5%
Accounts Payable, Current 1.67M USD +76.6%
Employee-related Liabilities, Current 767K USD +95.4%
Accrued Liabilities, Current 2.79M USD +91.5%
Liabilities, Current 6.32M USD +49.8%
Operating Lease, Liability, Noncurrent 3.1M USD -8.35%
Liabilities 9.66M USD +21.9%
Retained Earnings (Accumulated Deficit) -27.8M USD -75.5%
Stockholders' Equity Attributable to Parent 17.7M USD -35.4%
Liabilities and Equity 27.4M USD -22.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -347K USD +92.6%
Net Cash Provided by (Used in) Financing Activities -182K USD +23.8%
Net Cash Provided by (Used in) Investing Activities -133K USD +53.1%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 49.3M shares +0.44%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -662K USD +87.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.3K USD -0.24%
Deferred Tax Assets, Valuation Allowance 6.9M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Operating Lease, Liability 3.5M USD -6.5%
Depreciation 228K USD +14%
Lessee, Operating Lease, Liability, to be Paid 2.83M USD +2007%
Property, Plant and Equipment, Gross 7.89M USD +24.7%
Operating Lease, Liability, Current 396K USD +11.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 534K USD +6.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 133K USD +6.9%
Deferred Income Tax Expense (Benefit) 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Three 534K USD +6.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 534K USD +6.9%
Operating Lease, Payments 120K USD +5.76%
Depreciation, Depletion and Amortization 905K USD +9.12%
Deferred Tax Assets, Net of Valuation Allowance 3.97M USD +104%